Trial reportAsian Pacific journal of cancer prevention : APJCP2024
Effect of Channa striata Extract Supplementation on Febrile Neutropenia in Acute Myeloid Leukemia Patients Undergoing Chemotherapy: A Randomized Controlled Study.
Trial report in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFebrile neutropenia is one of the most serious complications in patients with hematological malignancies and chemotherapy. Channa striata is a freshwater fish belonging to the family Channidae. This study aims to determine whether the administration of channa striata extract can increase neutrophil count, neutrophil function and prevent incidence of febrile neutropenia in acute myeloid leukemia (AML) patients receiving chemotherapy.
methodA randomized, single-blind, controlled study compared a standard nutrition from hospital with a channa striata extract-supplemented per oral containing 6 grams of channa striata extract in patients with acute myeloid leukemia undergoing intensive chemotherapy. To analyze the effects of channa striata extract on function of neutrophil, Interleukin (IL)-6 and nitric oxide (NO) levels which are the result of neutrophil phagocytosis were assessed.
resultsA total of 32 AML patients were randomized to receive per oral supplementation of channa striata extract (6 g/day) or nutrition from the hospital during intensive chemotherapy and after chemotherapy. The median onset of neutropenia was 6.1 + 3.37 in the channa striata extract group and 8.8 + 4.59 in the control group (p=0.109). The median duration of neutropenia was 12.8 + 6.20 d in the channa striata group and 17.2 + 11.06 d in the control group (p=0.281), whereas the incidence of febrile neutropenia were 85,7% in the channa striata extract group and 43,8% in the control group with median duration of neutropenic fever were 5.7 + 3.56 and 4.7 + 4.57, respectively. The chi-square test in the IL-6 delta category showed a tendency for IL-6 levels to rise in 61.5% of subjects in the Channa striata group compared to the control group (p=0.182).
conclusionChanna striata extract supplementation did not influence neutropenia onset, duration, neutrophil function, or neutropenic fever in AML patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.